Palisade Bio (PALI) Non Operating Interest Expenses (2010 - 2026)
Palisade Bio's Non Operating Interest Expenses came in at $1,000 for Q1 2026, unchanged from $1,000 a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Palisade Bio (PALI) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
For FY2025, Palisade Bio's Non Operating Interest Expenses was $10,000, down 16.7% from FY2024.
- Non Operating Interest Expenses carries a five-year compound annual growth rate of -46.8% (FY2020 to FY2025).
- Going back by year, Non Operating Interest Expenses was $12,000 in FY2024 (-20.0%), $15,000 in FY2023 (+15.4%), $13,000 in FY2022 (-99.5%) and $2.4 million in FY2021 (+920.4%).
- The five-year range for quarterly Non Operating Interest Expenses is $1,000 (Q1 2022) to $655,000 (Q2 2021).
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q3 2023 (growth of 100.0%), and the weakest in Q1 2022 (a decline of 99.9%).
- Business Quant data shows PALI's Non Operating Interest Expenses at $2,000 (Q4 2025), $5,000 (Q3 2025) and $2,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Palisade Bio | 234.35 Mn | -162.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 655,000.00 |
| Mar 31, 2021 | 1.71 Mn |
API Access
Palisade Bio Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PALI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();